SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-23-003962
Filing Date
2023-12-26
Accepted
2023-12-26 08:00:25
Documents
18
Period of Report
2023-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk2330685.htm   iXBRL 8-K 46443
2 EXHIBIT 10.1 exhibit_10-1.htm EX-10.1 240042
3 EXHIBIT 10.2 exhibit_10-2.htm EX-10.2 99130
4 EXHIBIT 10.3 exhibit_10-3.htm EX-10.3 101165
5 EXHIBIT 10.4 exhibit_10-4.htm EX-10.4 99592
6 EXHIBIT 10.5 exhibit_10-5.htm EX-10.5 167656
  Complete submission text file 0001178913-23-003962.txt   1097248

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA entx-20231220.xsd EX-101.SCH 4677
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE entx-20231220_def.xml EX-101.DEF 18391
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE entx-20231220_lab.xml EX-101.LAB 28710
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE entx-20231220_pre.xml EX-101.PRE 20633
12 EXTRACTED XBRL INSTANCE DOCUMENT zk2330685_htm.xml XML 6879
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 231511385
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)